Ex Parte HERSH - Page 10


                  Appeal No. 2001-1177                                                         Page 10                     
                  Application No. 08/781,868                                                                               

                  1780, 1783 (Fed. Cir. 1992) (citations omitted).  “It is prima facie obvious to                          
                  combine two compositions each of which is taught by the prior art to be useful for                       
                  the same purpose, in order to form a third composition which is to be used for the                       
                  very same purpose. . . . [T]he idea of combining them flows logically from their                         
                  having been individually taught in the prior art.”  In re Kerkhoven, 626 F.2d 846,                       
                  850, 205 USPQ 1069, 1072 (CCPA 1980).                                                                    
                         Here, we agree that N’Guyen and Burke render the composition of                                   
                  claim 35 prima facie obvious.  N’Guyen and Burke teach compositions for                                  
                  treating skin aging and comprising glutathione and selenoamino acids,                                    
                  respectively.  It would have been obvious to combine the active ingredients of the                       
                  two compositions to make a third composition for treating skin aging, and                                
                  comprising both glutathione and selenoamino acids.                                                       
                         Appellant concedes that N’Guyen and Burke “relate equally to                                      
                  compositions to repair cutaneous aging, called photoaging, by known                                      
                  dermatologic processes.”  Appeal Brief, page 8.  He argues, however, that the                            
                  references do not support a prima facie case because they do not teach use of                            
                  the disclosed compositions “for the repair of damage to the skin from chemical                           
                  peels and thermal injury of laser surgery.”  Id., page 9.                                                
                         This argument is not persuasive.  As discussed above, claim 35 is                                 
                  directed to a composition and the preamble’s recitation of the intended use of                           
                  that composition does not limit the scope of the claimed composition.  The prior                         
                  art renders obvious a composition within the scope of claim 35, albeit for a                             







Page:  Previous  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  Next 

Last modified: November 3, 2007